X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

AstraZeneca is proud to support a new Insight by Nature on precision medicine

Yuvraj_pawp by Yuvraj_pawp
24th October 2015
in Facilities & Operation

AstraZeneca is proud to support a new Insight by Nature on precision medicine. Currently, 80% of our pipeline takes a precision medicine, or personalised healthcare, approach.

AstraZeneca is proud to support a Nature Insight describing advances in precision medicine. Precision medicine, or personalised healthcare, is an integral part of our approach to discovering and developing new medicines; we see this as the future of healthcare for patients and providers alike. This approach offers us the opportunity to identify novel disease targets, enrich clinical trials and demonstrate clear value to payers.

Most importantly, it increases our ability to make the right medicines for the different groups of patients who will benefit from them most. For AstraZeneca, precision medicine epitomizes what science can do. Today, more than 80% of our portfolio across small and large molecules has a precision medicine, or personalised healthcare approach.

We have launched five diagnostic tests linked to our products in 2015 alone and by 2020, we aim for half our medicine launches to be paired with a diagnostic test. We will achieve this by continuing to apply scientific rigour and being open for collaboration; in this way, we believe we can unlock the potential of precision medicine to eliminate therapeutic guesswork and transform the lives of patients around the world. 

Previous Post

AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination

Next Post

New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis

Related Posts

Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Facilities & Operation

Considerable Rise In Healthcare Deals Expected In 2023

16th January 2023
Facilities & Operation

Significant M&A Agreements Are On The Horizon For 2023

10th January 2023
Facilities & Operation

Cancer Treatment Rates In NHS Hit An All-Time High In 2022

5th January 2023
Facilities & Operation

Quality Assurance Advances In Pharmaceutical Manufacturing

19th December 2022
Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19
Facilities & Operation

India Keen To Establish National Database On Dosage Forms

9th December 2022
Next Post

New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In